Jesús Ruiz-Aragón
4PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 28, 2023
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion.Maarten Postma, David Fisman, Norberto Giglio
|Feb 26, 2022
Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain.Jesús Ruiz-Aragón, Sergio Márquez-Peláez, Ray Gani
|Feb 11, 2020
Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain.Jesús Ruiz-Aragón, Ray Gani, Sergio Márquez
Pageof 1
